GPCR Structure Therapeutics | $39.29 +0.8% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 5/3/2024 |
CYBR CyberArk Software | $227.32 -2.7% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 5/3/2024 |
REGN Regeneron Pharmaceuticals | $957.00 +2.1% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/3/2024 |
UDMY Udemy | $10.13 +2.4% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 5/3/2024 |
LBPH Longboard Pharmaceuticals | $21.38 -6.3% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/3/2024 |
ASND Ascendis Pharma A/S | $137.20 -2.8% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/3/2024 |
|
NET Cloudflare | $74.40 -16.4% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/3/2024 |
FTNT Fortinet | $58.88 -9.7% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 5/3/2024 |
CI The Cigna Group | $341.50 -0.9% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
RARE Ultragenyx Pharmaceutical | $42.75 -1.0% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/3/2024 |
CERS Cerus | $1.62 -8.0% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 5/3/2024 |
SPT Sprout Social | $28.82 -40.1% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 -> $46.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
CGON CG Oncology | $36.27 -8.2% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 5/2/2024 |
FRSH Freshworks | $14.03 -4.4% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $19.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
CSGS CSG Systems International | $41.70 -0.8% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $63.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 5/2/2024 |
QCOM QUALCOMM | $179.64 -0.3% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 5/2/2024 |
SRPT Sarepta Therapeutics | $133.66 +2.3% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2024 |
TSLA Tesla | $181.19 +0.7% | 5/2/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $230.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 5/2/2024 |
CVS CVS Health | $55.90 +1.4% | 5/1/2024 | Downgraded by | Cantor Fitzgerald | Analyst S. James | Overweight -> Neutral | $87.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 5/1/2024 |
AMD Advanced Micro Devices | $150.60 +3.0% | 5/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 5/1/2024 |
FUBO fuboTV | $1.37 -11.6% | 5/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.90 | Low | View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 5/1/2024 |
LLY Eli Lilly and Company | $734.97 -2.8% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/30/2024 |
NXPI NXP Semiconductors | $257.85 +1.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/30/2024 |
ATNM Actinium Pharmaceuticals | $8.96 +2.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/30/2024 |
CMPS COMPASS Pathways | $8.53 +3.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/30/2024 |
COUR Coursera | $9.61 +0.8% | 4/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/30/2024 |
ACAD ACADIA Pharmaceuticals | $17.05 -0.2% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/30/2024 |
TSHA Taysha Gene Therapies | $2.57 -0.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/30/2024 |
CMCL Caledonia Mining | $9.77 -2.2% | 4/29/2024 | Upgraded by | Cantor Fitzgerald | - | Hold -> Speculative Buy | $13.50 | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 4/29/2024 |
BMRN BioMarin Pharmaceutical | $82.44 -1.6% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $320.54 -0.1% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $10.09 +6.5% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $908.53 +2.8% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $120.44 +2.6% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $92.08 -0.4% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
TXN Texas Instruments | $178.91 +1.8% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $68.80 -2.2% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $4.88 +4.7% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $87.50 +1.4% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
MTLS Materialise | $5.39 +2.3% | 4/24/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
Automatic Income (from home) (Ad) For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors…
6 simple clicks have set up HUGE payouts for "in-the-know" investors…
Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. |
ABEO Abeona Therapeutics | $4.60 +13.0% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $12.51 -1.3% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $53.76 +1.3% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $2.57 -0.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $137.20 -2.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $40.69 +2.0% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
GPCR Structure Therapeutics | $39.29 +0.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $127.51 -0.6% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $123.05 -0.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $8.53 +3.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $9.61 +0.8% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $310.21 +2.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $227.32 -2.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $124.27 -0.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $58.88 -9.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $74.40 -16.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $296.21 +0.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $177.11 +0.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $22.48 -0.1% | 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $957.00 +2.1% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
LLY Eli Lilly and Company | $734.97 -2.8% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $149.27 -0.4% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $27.81 +0.4% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
ALXO ALX Oncology | $15.36 -7.6% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $1.34 -2.2% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $68.51 +2.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $31.57 -0.4% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $33.01 -1.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $4.50 +0.2% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
PRTA Prothena | $22.93 +4.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $40.69 +2.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $12.47 +0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $24.53 -1.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $8.53 +0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $120.28 +1.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $167.70 -1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $492.45 -0.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $3.21
| 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $17.05 -0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $74.80 +0.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $110.01 +0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $21.38 -6.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.51 +4.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $140.71 +0.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $43.75 +1.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $341.50 -0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $55.90 +1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $526.96 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $307.76 -0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
HCAT Health Catalyst | $6.48 -0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
Automatic Income (from home) (Ad) For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors…
6 simple clicks have set up HUGE payouts for "in-the-know" investors…
Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. |
HUM Humana | $320.54 -0.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $34.54 -0.1% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.88 -5.4% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $39.29 +0.8% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $257.85 +1.4% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $696.59 +2.1% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $908.53 +2.8% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $114.70 +2.1% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $179.64 -0.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $178.91 +1.8% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $70.95 +1.8% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $49.27 +2.1% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $204.09 +3.1% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $12.39 -1.7% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $42.75 -1.0% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $9.22 +4.1% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |
MRK Merck & Co., Inc. | $127.51 -0.6% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/5/2024 |
MOH Molina Healthcare | $339.68 +0.0% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 4/4/2024 |
UNH UnitedHealth Group | $492.45 -0.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/4/2024 |
SPRO Spero Therapeutics | $1.63 +1.2% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 4/4/2024 |
STOK Stoke Therapeutics | $12.02 +2.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 4/4/2024 |
ATAI Atai Life Sciences | $2.05 -3.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 4/4/2024 |
PRE Prenetics Global | $5.23 -1.9% | 4/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 4/4/2024 |
CNC Centene | $74.81 +0.6% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 4/4/2024 |
CVS CVS Health | $55.90 +1.4% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/4/2024 |
ELV Elevance Health | $526.96 +0.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/4/2024 |
HUM Humana | $320.54 -0.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/4/2024 |
TNGX Tango Therapeutics | $7.61 +0.3% | 4/4/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 4/4/2024 |
INTC Intel | $30.90 +1.3% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/3/2024 |
ANNX Annexon | $4.88 +4.7% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/3/2024 |
PRCH Porch Group | $3.44 +3.6% | 4/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $3.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 4/3/2024 |
RIVN Rivian Automotive | $10.07 +2.4% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 4/3/2024 |
LEGN Legend Biotech | $45.41 -1.1% | 4/3/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 4/3/2024 |
AFMD Affimed | $5.42 +2.3% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
CRVS Corvus Pharmaceuticals | $1.92 +11.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 4/1/2024 |
VINC Vincerx Pharma | $0.88 -5.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $8.96 +2.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
AWH Aspira Women's Health | $3.21
| 4/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/1/2024 |
HUMA Humacyte | $4.41 +0.2% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 4/1/2024 |
ZVRA Zevra Therapeutics | $4.81 +1.3% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/1/2024 |
SCYX SCYNEXIS | $1.77 -0.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 4/1/2024 |
ASND Ascendis Pharma A/S | $137.20 -2.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/1/2024 |
LLY Eli Lilly and Company | $734.97 -2.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/1/2024 |
NVO Novo Nordisk A/S | $123.05 -0.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/1/2024 |
PFE Pfizer | $27.81 +0.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/1/2024 |
MIGI Mawson Infrastructure Group | $1.29 +4.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1.00 | Low | View details for Cantor Fitzgerald rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/1/2024 |
EVLV Evolv Technologies | $3.88 -0.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/28/2024 |
CMCL Caledonia Mining | $9.77 -2.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Speculative Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 3/28/2024 |
CLSK CleanSpark | $16.15 +1.3% | 3/28/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $20.00 | N/A | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 3/28/2024 |
BITF Bitfarms | $1.82 +1.1% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 3/28/2024 |
Automatic Income (from home) (Ad) For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors…
6 simple clicks have set up HUGE payouts for "in-the-know" investors…
Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. |
CIFR Cipher Mining | $4.14 +5.3% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/28/2024 |
IREN Iris Energy | $4.73 +3.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 3/28/2024 |
RIOT Riot Platforms | $10.42 +1.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/28/2024 |
WULF TeraWulf | $2.19 +0.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/28/2024 |
OUST Ouster | $9.66 +0.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/28/2024 |
MREO Mereo BioPharma Group | $3.26 +4.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/28/2024 |
HRMY Harmony Biosciences | $31.57 -0.4% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 3/28/2024 |
CXM Sprinklr | $11.93 +0.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ZS Zscaler | $177.11 +0.4% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/27/2024 |
MRK Merck & Co., Inc. | $127.51 -0.6% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2024 |
VNRX VolitionRx | $0.89 +1.1% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 3/27/2024 |
SMTI Sanara MedTech | $32.44 +4.6% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 -> $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/27/2024 |
LUCD Lucid Diagnostics | $0.93 -2.1% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.80 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/27/2024 |
LUNR Intuitive Machines | $5.57 +7.9% | 3/22/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $110.01 +0.7% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
CLDX Celldex Therapeutics | $42.56 +4.2% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 3/22/2024 |
CABA Cabaletta Bio | $12.39 -1.7% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
DESP Despegar.com | $12.30 -0.6% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/22/2024 |
MREO Mereo BioPharma Group | $3.26 +4.8% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/22/2024 |
CPRX Catalyst Pharmaceuticals | $14.72 -2.0% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/22/2024 |
SOUN SoundHound AI | $4.50 +0.2% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Underweight | $5.80 -> $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/20/2024 |
NVO Novo Nordisk A/S | $123.05 -0.8% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 3/20/2024 |
TSHA Taysha Gene Therapies | $2.57 -0.4% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/20/2024 |
WULF TeraWulf | $2.19 +0.9% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/20/2024 |
JANX Janux Therapeutics | $64.78 +3.8% | 3/20/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 3/20/2024 |
BBIO BridgeBio Pharma | $27.83 +0.3% | 3/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/19/2024 |
SHLS Shoals Technologies Group | $9.00 +3.1% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $21.38 -6.3% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $10.07 +2.3% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |
JNJ Johnson & Johnson | $149.27 -0.4% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 3/13/2024 |
CRWD CrowdStrike | $310.21 +2.2% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/14/2024 |
CPRX Catalyst Pharmaceuticals | $14.72 -2.0% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/14/2024 |
MNKD MannKind | $4.39 +0.2% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 3/15/2024 |
DESP Despegar.com | $12.30 -0.6% | 3/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/15/2024 |
SSTI SoundThinking | $13.48 -0.1% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 3/15/2024 |
MU Micron Technology | $114.70 +2.1% | 3/18/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/18/2024 |
RNA Avidity Biosciences | $26.45 +3.4% | 3/14/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Avidity Biosciences (NASDAQ:RNA) on 3/14/2024 |
FROG JFrog | $39.89 +0.4% | 3/7/2024 | Target Raised by | Cantor Fitzgerald | - | | $40.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EVGO EVgo | $1.99 +4.7% | 3/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $5.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 3/7/2024 |
ISPO Inspirato | $3.93 -1.8% | 3/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Inspirato (NASDAQ:ISPO) on 3/7/2024 |
DESP Despegar.com | $12.30 -0.6% | 3/7/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/7/2024 |
CIFR Cipher Mining | $4.14 +5.3% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/6/2024 |
NPCE NeuroPace | $13.64 -1.9% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $16.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/6/2024 |
CERS Cerus | $1.62 -8.0% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 3/6/2024 |
CRWD CrowdStrike | $310.21 +2.2% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $360.00 -> $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.20 +4.3% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
THC Tenet Healthcare | $120.28 +1.1% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 3/5/2024 |
ACHC Acadia Healthcare | $66.12 -0.9% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 3/5/2024 |
HCA HCA Healthcare | $307.76 -0.3% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 3/5/2024 |
HCAT Health Catalyst | $6.48 -0.9% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 3/5/2024 |
Automatic Income (from home) (Ad) For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors…
6 simple clicks have set up HUGE payouts for "in-the-know" investors…
Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. |
RCM R1 RCM | $12.47 +0.2% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 3/5/2024 |
SGRY Surgery Partners | $24.53 -1.9% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 3/5/2024 |
TBRG TruBridge | $8.53 +0.2% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/5/2024 |
GTLB GitLab | $54.54 +0.2% | 3/5/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/5/2024 |
NVDA NVIDIA | $887.89 +3.5% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $900.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/4/2024 |
NXPI NXP Semiconductors | $257.85 +1.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 3/4/2024 |
TXN Texas Instruments | $178.91 +1.8% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 3/4/2024 |
QCOM QUALCOMM | $179.64 -0.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 3/4/2024 |
TER Teradyne | $120.44 +2.6% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/4/2024 |
STX Seagate Technology | $87.50 +1.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 3/4/2024 |
AVGO Broadcom | $1,278.11 +3.2% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 -> $1,600.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/4/2024 |
AMAT Applied Materials | $204.09 +3.1% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 3/4/2024 |
AMD Advanced Micro Devices | $150.60 +3.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 3/4/2024 |
KLAC KLA | $696.59 +2.1% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 3/4/2024 |
LRCX Lam Research | $908.53 +2.8% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 3/4/2024 |
ADI Analog Devices | $199.63 +1.6% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 3/4/2024 |
CI The Cigna Group | $341.50 -0.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $372.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/4/2024 |
PAGS PagSeguro Digital | $12.81 +1.7% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $16.00 | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 3/4/2024 |
CRNX Crinetics Pharmaceuticals | $47.20 +0.9% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/4/2024 |
RIOT Riot Platforms | $10.42 +1.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/4/2024 |
ETNB 89bio | $9.22 +4.1% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 3/4/2024 |
BBAI BigBear.ai | $1.49 -13.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/4/2024 |
EVLV Evolv Technologies | $3.88 -0.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/1/2024 |
PTCT PTC Therapeutics | $33.01 -1.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 3/1/2024 |
AVPT AvePoint | $8.14 +1.2% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 3/1/2024 |
SOUN SoundHound AI | $4.50 +0.2% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.60 -> $5.80 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
MVIS MicroVision | $1.61 +1.9% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.00 | Low | View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 3/1/2024 |
PFE Pfizer | $27.81 +0.4% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 3/1/2024 |
ZS Zscaler | $177.11 +0.4% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $250.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
CPRX Catalyst Pharmaceuticals | $14.72 -2.0% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $27.00 -> $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/1/2024 |
PAYO Payoneer Global | $5.08 +1.6% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Payoneer Global (NASDAQ:PAYO) on 3/1/2024 |
ORGO Organogenesis | $2.49
| 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 3/1/2024 |
MIRM Mirum Pharmaceuticals | $25.84 +0.9% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/29/2024 |
SRPT Sarepta Therapeutics | $133.66 +2.3% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
SHLS Shoals Technologies Group | $9.00 +3.1% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $28.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
CYBR CyberArk Software | $227.32 -2.7% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 2/29/2024 |
MRK Merck & Co., Inc. | $127.51 -0.6% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/29/2024 |
FOLD Amicus Therapeutics | $10.40 -0.3% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 2/29/2024 |
DCGO DocGo | $3.61 +2.8% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 2/29/2024 |
ADMA ADMA Biologics | $6.81 +1.0% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 -> $8.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 2/29/2024 |
LUNR Intuitive Machines | $5.57 +7.9% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/29/2024 |
UHS Universal Health Services | $167.70 -1.3% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Underweight -> Underweight | $148.00 -> $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $110.01 +0.7% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
TDOC Teladoc Health | $12.78 -1.6% | 2/29/2024 | Initiated by | Cantor Fitzgerald | Analyst S. James | Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Teladoc Health (NYSE:TDOC) on 2/29/2024 |
MNKD MannKind | $4.39 +0.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
ACAD ACADIA Pharmaceuticals | $17.05 -0.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/28/2024 |
ARRY Array Technologies | $13.46 +3.1% | 2/28/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
SSTI SoundThinking | $13.48 -0.1% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/28/2024 |
PGNY Progyny | $31.72 -1.1% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 2/28/2024 |
MKFG Markforged | $0.63 +1.6% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $1.45 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 2/28/2024 |
DM Desktop Metal | $0.86 +7.5% | 2/28/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $1.25 | Low | View details for Cantor Fitzgerald rating of Desktop Metal (NYSE:DM) on 2/28/2024 |
SIBN SI-BONE | $14.20 -2.8% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/27/2024 |
ACHR Archer Aviation | $3.96 -1.2% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $42.75 -1.0% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
BBAI BigBear.ai | $1.49 -13.9% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/27/2024 |
RCKT Rocket Pharmaceuticals | $23.47 +3.1% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/27/2024 |
SGRY Surgery Partners | $24.53 -1.9% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 2/27/2024 |
GENI Genius Sports | $5.32 +1.1% | 2/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Genius Sports (NYSE:GENI) on 2/26/2024 |
BMRN BioMarin Pharmaceutical | $82.44 -1.6% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/23/2024 |
HRMY Harmony Biosciences | $31.57 -0.4% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 2/23/2024 |